Table 3. ORs From All 4 Pathologists (Blinded to C4d Results) for the 9 Variables With the Strongest Correlations With C4d-Positive Rejection in the UPMC Training Cohort and the Edinburgh University/BUMC Validation Cohorts.
Training Cohort | OR (CI) | P Value | Coefficient of Concordance* |
---|---|---|---|
Eosinophilic central venulitis | 1.93 (1.25-2.96) | 0.003 | 0.49 |
Portal vein endothelial cell hypertrophy | 1.89 (1.19-2.99) | 0.007 | 0.42 |
Eosinophilic portal venulitis | 2.48 (1.24-4.96) | 0.01 | 0.30 |
Central venulitis severity | 2.26 (1.20-4.25) | 0.02 | 0.33 |
L ymphocytic portal inflammation | 0.59 (0.34-1.03) | 0.06 | 0.40 |
Portal eosinophilia | 1.43 (0.92-2.21) | 0.11 | 0.40 |
L ymphocytic venulitis | 0.78 (0.49-1.24) | 0.30 | 0.32 |
Hepatocyte ballooning | 1.14 (0.76-1.72) | 0.53 | 0.44 |
Cholestasis | 1.00 (0.71-1.42) | 1.00 | 0.29 |
Validation Cohort | OR (CI) | P Value | Coefficient of Concordance* |
---|---|---|---|
Eosinophilic central venulitis | 2.48 (1.37-4.49) | 0.003 | 0.63 |
Portal vein endothelial cell hypertrophy | 2.88 (1.83-4.55) | <0.001 | 0.62 |
Eosinophilic portal venulitis | 3.05 (1.96-4.69) | <0.001 | 0.38 |
Central venulitis severity | 2.44 (1.47-4.06) | <0.001 | 0.63 |
L ymphocytic portal inflammation | 1.33 (0.79-2.22) | 0.30 | 0.58 |
Portal eosinophilia | 4.37 (2.54-7.51) | <0.001 | 0.61 |
L ymphocytic venulitis | 1.65 (1.05-2.58) | 0.03 | 0.42 |
Hepatocyte ballooning | 2.00 (1.35-2.95) | <0.001 | 0.63 |
Cholestasis | 2.09 (1.35-2.95) | <0.001 | 0.65 |
Kendall's coefficient of concordance displays the interobserver variability.